Full Text
PCV89 COST EFFECTIVENESS OF PRASAGREL OR CHOPIDOGREL FOR TREATMENT OF ACS PATIENTS BASED ON GENETIC TESTING FOR CYP2C19 VARIANTS

Abstract

Authors

L Panattoni P Brown

Back to Volume 13, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×